Perioperative the BTLA inhibitor (tifcemalimab) combined with toripalimab and chemotherapy for resectable locally advanced thoracic esophageal squamous cell carcinoma trial (BT-NICE trial): a prospective, single-arm, exploratory study - Ding, Chengzhi; Zhang, Yahao; Xia, Tian; Li, Jiwei; Yao, Wenjian; Zhang, Quan; Han, Zhijun; Wang, Jianjun; Cao, Zhikun; Hu, Jinlong; Wei, Li (Frontiers in Immunology, 2025)